ARTEMIS BIOTECHNOLOGY LIMITED

Yes. Pursuant to the statutory registers of the Hong Kong Companies Registry, ARTEMIS BIOTECHNOLOGY LIMITED was officially incorporated on 2015-01-30 as a Private company limited by shares (standing for 11 years). Official cross-departmental records confirm its current legal status is [Live / In Operation], maintaining valid operational standing under Hong Kong law (Verified: January 2024).

Under Hong Kong's Unique Business Identifier (UBI) regime, ARTEMIS BIOTECHNOLOGY LIMITED is identified by two official registration numbers: its 8-digit Business Registration Number (BRN / UBI) [64363630] administered by the Inland Revenue Department, and its 7-digit Company Registration Number (CRN) [2198307] maintained by the Companies Registry for historical statutory filings.

Pursuant to Sections 627 and 643 of the Hong Kong Companies Ordinance (Cap. 622), the equity ownership and executive board of ARTEMIS BIOTECHNOLOGY LIMITED are governed by its statutory Register of Members and Register of Directors. Any appointment or resignation of directors or the company secretary must be filed within 15 days via Form ND2A, while complete shareholder equity ratios are disclosed annually in Form NAR1. Furthermore, under Section 653H of Cap. 622, the company must maintain a Significant Controllers Register (SCR) for persons holding over 25% beneficial interest or voting rights.

Yes. According to the official statutory records of the Hong Kong Companies Registry, ARTEMIS BIOTECHNOLOGY LIMITED has officially recorded 2 legal name change(s): [GOLD TREASURE LIMITED (金晴有限公司) (effective 2015-01-30)], [ARTEMIS BEAUTY SUPPLIES LIMITED (亞特米斯有限公司) (effective 2015-11-23)]. Pursuant to Sections 107 and 109 of the Companies Ordinance (Cap. 622), each name change was passed by special resolution (Form NNC2) and took statutory effect upon issuance of a Certificate of Change of Name by the Registrar of Companies; under Section 109(4), changing the company name does not affect any rights, obligations, or legal proceedings of the company.

Pursuant to the Companies Ordinance (Cap. 622), statutory filings delivered by ARTEMIS BIOTECHNOLOGY LIMITED—such as Incorporation Forms (Form NNC1), Annual Returns (Form NAR1 under Section 662), and notices of director or registered office changes (Form ND2A / Form NR1)—are maintained by the Hong Kong Companies Registry. Where online electronic image indexing is pending synchronization or involves early historical microfiche archives, manual statutory retrieval from the Companies Registry can be commissioned through our compliance team.

According to multi-dimensional checks across Hong Kong statutory authorities: 1. Statutory Licensing Standing: Screened against Hong Kong's statutory licensing databases (SFC Public Register, HKMA Register, TCSP Registry, and Customs MSO), ARTEMIS BIOTECHNOLOGY LIMITED is registered as an ordinary commercial company without regulated financial activity licensing requirements; 2. Judicial Screening (Litigation & Winding-Up): no compulsory winding-up petitions (HCCW) or public High Court / District Court litigation writs were identified for ARTEMIS BIOTECHNOLOGY LIMITED in current public judicial indexing. For major cross-border M&A or credit facilities, an up-to-the-minute court registry search is recommended.

Official filings of the Hong Kong Companies Registry record the statutory registered office of ARTEMIS BIOTECHNOLOGY LIMITED at: [6/F, L. PLAZA, 9 KAI CHEUNG ROAD, KOWLOON BAY, HONG KONG]. Under Section 658 of the Companies Ordinance (Cap. 622), a document or court writ may be lawfully served on a company by leaving it at, or sending it by post to, this registered office. Where the address is domiciled at a licensed TCSP company secretary's premises, Cap. 622B Section 3 permits statutory name display via a compliant electronic signboard system.

Unlike jurisdictions with government ICP domain licensing, Hong Kong regulates corporate identity disclosure under Section 4 of the Companies (Disclosure of Company Name and Liability Status) Regulation (Cap. 622B): ARTEMIS BIOTECHNOLOGY LIMITED must legibly display its exact registered name on all business letters, contracts, invoices, and any company website, and report its website (if any) in its Annual Return (Form NAR1) or Form NR2. To prevent cross-border impersonation, trade partners should authenticate the company's legal standing via its statutory identifiers (CRN: 2198307 / 8-digit BRN: 64363630) and barcoded Companies Registry dossiers rather than unverified external web pages.